Therefore, in this study, we investigated the effects of the combination of IL-2 and a calcineurin inhibitor on Tregs and disease symptoms in a murine model of SLE-like chronic GVHD (cGVHD). The gene discussed is IL2; the disease is systemic lupus erythematosus.